...
首页> 外文期刊>Iranian red crescent medical journal >RNAi-Mediated Knockdown of Skp2 Inhibits Human Bladder Cancer Proliferation and Invasion in T24 Cells
【24h】

RNAi-Mediated Knockdown of Skp2 Inhibits Human Bladder Cancer Proliferation and Invasion in T24 Cells

机译:RNAi介导的Skp2基因敲低抑制人膀胱癌T24细胞的增殖和侵袭。

获取原文
           

摘要

Background: Skp2 (S-phase kinase-associated protein 2 is overexpressed in many kinds of cancers, and is related to the occurrence and development of tumors. The molecular mechanism of Skp2 in the regulation of bladder cancer cell biological behavior after Skp2 expression knockdown, however, has remained unknown. Objectives: In our present studies (experimental cytobiological studies, we used an RNAi approach to knock down Skp2 expression, and studied its impact on cell proliferation and invasion of T24 cells. Materials and Methods: The expression of the Skp2 gene was knocked down by RNA interference (RNAi) in T24 cells. The transcription level of Skp2 was detected by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis. The expression of Skp2, caspase-3, caspase-8, caspase-9, and p27 (p27Kip1) were measured by western blot assay. Cell proliferation and apoptosis were detected by MTT and flow cytometry. Cell invasion analysis was performed by a matrigel transwell assay. We also detected the level of MMP2 (metalloproteinase-2) and MMP9 (metalloproteinase-9) in cell culture medium by ELISA. Results: The levels of Skp2 mRNA in the negative control group (0.911 ± 0.073) and the blank control group (0.940 ± 0.046) was significantly higher than Skp2 RNAi group (0.185 ± 0.033) (P < 0.001). The levels of Skp2 protein in the negative control group (0.907 ± 0.049) and the blank control group (0.925 ± 0.042) was significantly higher than Skp2 RNAi group (0.220 ± 0.047) (P < 0.001). The proliferation and invasion of T24 cells were significantly inhibited in vitro upon Skp2 RNAi treatment. Conclusions: The proliferation and invasion of human bladder cancer cells can be inhibited by RNAi-targeting Skp2. As a result, Skp2 may be a potential target for gene the
机译:背景:Skp2(S期激酶相关蛋白2在多种癌症中均过表达,并且与肿瘤的发生和发展有关。Skp2调控Skp2表达敲低后调节膀胱癌细胞生物学行为的分子机制,目的:在我们目前的研究中(实验细胞生物学研究,我们使用RNAi方法来抑制Skp2的表达,并研究了其对T24细胞增殖和侵袭的影响。材料与方法:Skp2的表达RNA干扰(RNAi)在T24细胞中敲除该基因,通过逆转录定量聚合酶链反应(RT-qPCR)分析检测Skp2的转录水平,表达Skp2,caspase-3,caspase-8,caspase用Western blot法检测-9,p27(p27Kip1),MTT和流式细胞仪检测细胞增殖和凋亡,用基质胶法进行细胞侵袭分析。 ell分析。我们还通过ELISA检测了细胞培养基中MMP2(金属蛋白酶2)和MMP9(金属蛋白酶9)的水平。结果:阴性对照组(0.911±0.073)和空白对照组(0.940±0.046)的Skp2 mRNA水平显着高于Skp2 RNAi组(0.185±0.033)(P <0.001)。阴性对照组(0.907±0.049)和空白对照组(0.925±0.042)的Skp2蛋白水平显着高于Skp2 RNAi组(0.220±0.047)(P <0.001)。 Skp2 RNAi处理可显着抑制T24细胞的增殖和侵袭。结论:RNAi靶向Skp2可抑制人膀胱癌细胞的增殖和侵袭。结果,Skp2可能是基因的潜在靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号